601514-19-6 | 3-[[6-(3-Aminophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]phenol

Packsize	Purity	Availability	Price	Discounted Price
1mg	≥90%	in stock	$48.00	$34.00
5mg	95%	in stock	$63.00	$45.00
10mg	95%	in stock	$105.00	$74.00
25mg	95%	in stock	$203.00	$142.00
50mg	95%	in stock	$366.00	$256.00
100mg	95%	in stock	$515.00	$361.00

Description

• Catalog Number: AB49449
• Chemical Name: 3-[[6-(3-Aminophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]phenol
• CAS Number: 601514-19-6
• Molecular Formula: C18H14N4O2
• Molecular Weight: 318.3294
• MDL Number: MFCD09037535
• SMILES: Oc1cccc(c1)Oc1ncnc2c1cc([nH]2)c1cccc(c1)N

Computed Properties

• Complexity: 424
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 24
• Hydrogen Bond Acceptor Count: 5
• Hydrogen Bond Donor Count: 3
• Rotatable Bond Count: 3
• XLogP3: 3.2

Literature

• Involvement of insulin signalling pathway in methamphetamine-induced hyperphosphorylation of Tau.

  Toxicology 20180901

• A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.

  The Biochemical journal 20130415

• Roles of glycogen synthase kinase 3 in Alzheimer's disease.

  Current Alzheimer research 20120901

• Selectively silencing GSK-3 isoforms reduces plaques and tangles in mouse models of Alzheimer's disease.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20120523

• Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity.

  Nature biotechnology 20111101

• Identification of new inhibitors of protein kinase R guided by statistical modeling.

  Bioorganic & medicinal chemistry letters 20110701

• GSK-3β negatively regulates megakaryocyte differentiation and platelet production from primary human bone marrow cells in vitro.

  Platelets 20110101

• A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.

  Proceedings of the National Academy of Sciences of the United States of America 20071218

• Synthetic small molecules that control stem cell fate.

  Proceedings of the National Academy of Sciences of the United States of America 20030624

• Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes.

  Diabetes 20000201

• Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice.

  Diabetes 19990801

• Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity.

  Proceedings of the National Academy of Sciences of the United States of America 19930815